Prediction of <sup>177</sup>Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on <sup>68</sup>Ga-DOTATATE PET/CT

Prediction of <sup>177</sup>Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on <sup>68</sup>Ga-DOTATATE PET/CT

Background: Treatment of metastatic neuroendocrine tumors (NET) with <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) results in favorable response only in a subset of patients. We investigated the prognostic value of quantitative pre-treatment semi-automatic <su...

Full description

Bibliographic Details
Main Authors: Hwan Lee, Sarit T. Kipnis, Remy Niman, Sophia R. O’Brien, Jennifer R. Eads, Bryson W. Katona, Daniel A. Pryma
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
neuroendocrine tumor
<sup>68</sup>Ga-DOTATATE
positron emission tomography computed tomography
<sup>177</sup>Lu-DOTATATE
prognostic factor
Online Access:https://www.mdpi.com/2072-6694/16/1/200

Internet

https://www.mdpi.com/2072-6694/16/1/200

Similar Items